Presentation is loading. Please wait.

Presentation is loading. Please wait.

World Health Organization

Similar presentations


Presentation on theme: "World Health Organization"— Presentation transcript:

1 World Health Organization
30 January, 2018 Countries using and planning to introduce IPV

2 Countries using and planning to introduce IPV May 2015 status report
World Health Organization 30 January 2018 Countries using and planning to introduce IPV May 2015 status report This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV). Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this data. Definitions Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for GAVI eligible countries, a complete application for IPV has been submitted to the GAVI Secretariat. Intent to introduce: The country has informally indicated that it plans to introduce IPV, e.g. planning an application to GAVI, or by requesting technical assistance to develop an IPV introduction plan. Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3 World Health Organization
Countries using IPV vaccine to date and formal decision/intent to introduce World Health Organization 30 January, 2018 Introduced to date Albania, Andorra, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Canada, China, Colombia, Comoros (the), Costa Rica, Croatia, Cyprus, Czech Republic (the), Denmark, DPR Korea, DR Congo, Estonia, Finland, France, Gambia (the), Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands (the), Mexico, Micronesia (Federated States of), Monaco, Montenegro, Nepal, Netherlands (the), New Zealand, Nigeria, Niue, Norway, Oman, Palau, Panama, Peru, Philippines (the), Poland, Portugal, Qatar, Rep of Korea, Romania, Russian Federation (the), San Marino, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Syrian Arab Republic (the), Tunisia, Turkey, Ukraine, United Arab Emirates (the), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Uruguay Formal commitment to introduce in 2015 Afghanistan, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Bahamas (the), Barbados, Belize, Benin, Bhutan, Bolivia (Plurinational State of), Botswana, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic (the), Chad, Chile, Congo (the), Cote d'Ivoire, Cuba, Djibouti, Dominica, Dominican Republic (the), Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Kenya, Kiribati, Kyrgyzstan, Lao People's Democratic Republic (the), Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nicaragua, Niger (the), Pakistan, Papua New Guinea, Paraguay, Republic of Moldova (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Seychelles, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan (the), Suriname, Swaziland, Tajikistan, The former Yugoslav Republic of Macedonia, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Turkmenistan, Tuvalu, Uganda, United Republic of Tanzania (the), Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe Intend to introduce in 2015 Cook Islands, Fiji, Mauritius, Thailand Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & ; Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo and Gambia (April 2015) Introduced to date (87 countries or 45%) Formal commitment to introduce in 2015 (103 countries or 53%) Intend to introduce in 2015 (Cook Islands, Fiji, Mauritius, Thailand) (4 countries or 2%) Data source: WHO/IVB Database, as of 01 May 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Date of slide: 1 May 2015

4 World Health Organization
Countries using IPV vaccine to date and introductions planned according to Gavi eligibility status World Health Organization 30 January, 2018 Introduced to date Albania, Andorra, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Canada, China, Colombia, Comoros (the), Costa Rica, Croatia, Cyprus, Czech Republic (the), Denmark, DPR Korea, DR Congo, Estonia, Finland, France, Gambia (the), Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands (the), Mexico, Micronesia (Federated States of), Monaco, Montenegro, Nepal, Netherlands (the), New Zealand, Nigeria, Niue, Norway, Oman, Palau, Panama, Peru, Philippines (the), Poland, Portugal, Qatar, Rep of Korea, Romania, Russian Federation (the), San Marino, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Syrian Arab Republic (the), Tunisia, Turkey, Ukraine, United Arab Emirates (the), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Uruguay Gavi countries with formal commitment to introduce in 2015 Afghanistan, Angola, Armenia, Azerbaijan, Benin, Bhutan, Bolivia (Plurinational State of), Burkina Faso, Burundi, Cambodia, Cameroon, Central African Republic (the), Chad, Congo (the), Cote d'Ivoire, Cuba, Djibouti, Eritrea, Ethiopia, Georgia, Ghana, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Kenya, Kiribati, Kyrgyzstan, Lao People's Democratic Republic (the), Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mongolia, Mozambique, Myanmar, Nicaragua, Niger (the), Pakistan, Papua New Guinea, Republic of Moldova (the), Rwanda, Sao Tome and Principe, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan (the), Tajikistan, Timor-Leste, Togo, Uganda, United Republic of Tanzania (the), Uzbekistan, Viet Nam, Yemen, Zambia, Zimbabwe Non Gavi countries with formal commitment to introduce in 2015 Algeria, Antigua and Barbuda, Argentina, Bahamas (the), Barbados, Belize, Botswana, Cabo Verde, Chile, Dominica, Dominican Republic (the), Ecuador, Egypt, El Salvador, Equatorial Guinea, Gabon, Grenada, Guatemala, Iran (Islamic Republic of), Iraq, Jamaica, Morocco, Namibia, Nauru, Paraguay, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Seychelles, Suriname, Swaziland, The former Yugoslav Republic of Macedonia, Tonga, Trinidad and Tobago, Turkmenistan, Tuvalu, Vanuatu, Venezuela (Bolivarian Republic of) Non Gavi countries with intent to introduce in 2015 Cook Islands, Fiji, Mauritius, Thailand Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo and Gambia (April 2015) Introduced to date (87 countries or 45%) Gavi countries with formal commitment to introduce in 2015 (64 countries or 33%) Non Gavi countries with formal commitment to introduce in 2015 (39 countries or 20%) Non Gavi countries with intent to introduce in 2015 (Cook Islands, Fiji, Mauritius, Thailand) (4 countries or 2%) Data source: WHO/IVB Database, as of 01 May 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Date of slide: 1 May 2015

5 107 countries introducing IPV between May 2015 and December 2015
World Health Organization 107 countries introducing IPV between May 2015 and December 2015 30 January, 2018 Yemen and Mauritius are introducing in 2015 but no month of introduction available. Source: WHO/UNICEF database as at 01 May 2015 Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC

6 World Health Organization
64/73 Gavi countries introducing IPV between May 2015 and December 2015 30 January, 2018 Yemen is introducing in 2015 but no month of introduction available. Source: WHO/UNICEF database as at 01 May 2015 Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC

7 World Health Organization
Tier 1 and 2 Countries using IPV vaccine to date and formal decision to introduce World Health Organization 30 January, 2018 Introduction to date Afghanistan, Azerbaijan, Benin, Cambodia, Cameroon, Central African Republic (the), Chad, Congo (the), Dominican Republic (the), Equatorial Guinea, Ethiopia, Gabon, Guinea, Haiti, India, Indonesia, Iraq, Kenya, Lao People's Democratic Republic (the), Madagascar, Mali, Mauritania, Mozambique, Myanmar, Niger (the), Pakistan, Papua New Guinea, Somalia, South Sudan, Timor-Leste, Yemen Formal commitment to introduce in 2015 China, DR Congo, Nigeria, Philippines (the) Not Applicable or not Tier 1 or 2 countries Angola, Albania, Andorra, United Arab Emirates (the), Argentina, Armenia, Antigua and Barbuda, Australia, Austria, Burundi, Belgium, Burkina Faso, Bangladesh, Bulgaria, Bahrain, Bahamas (the), Bosnia and Herzegovina, Belarus, Belize, Bolivia (Plurinational State of), Brazil, Barbados, Brunei Darussalam, Bhutan, Botswana, Canada, Switzerland, Chile, Cote d'Ivoire, Cook Islands, Colombia, Comoros (the), Cabo Verde, Costa Rica, Cuba, Cyprus, Czech Republic (the), Germany, Djibouti, Dominica, Denmark, Algeria, Ecuador, Egypt, Eritrea, Spain, Estonia, Finland, Fiji, France, Micronesia (Federated States of), United Kingdom of Great Britain and Northern Ireland (the), Georgia, Ghana, Gambia (the), Guinea-Bissau, Greece, Grenada, Guatemala, Guyana, Honduras, Croatia, Hungary, Ireland, Iran (Islamic Republic of), Iceland, Israel, Italy, Jamaica, Jordan, Japan, Kazakhstan, Kyrgyzstan, Kiribati, Saint Kitts and Nevis, Rep of Korea, Kuwait, Lebanon, Liberia, Libya, Saint Lucia, Sri Lanka, Lesotho, Lithuania, Luxembourg, Latvia, Morocco, Monaco, Republic of Moldova (the), Maldives, Mexico, Marshall Islands (the), The former Yugoslav Republic of Macedonia, Malta, Montenegro, Mongolia, Mauritius, Malawi, Malaysia, Namibia, Nicaragua, Niue, Netherlands (the), Norway, Nepal, Nauru, New Zealand, Oman, Panama, Peru, Palau, Poland, DPR Korea, Portugal, Paraguay, Qatar, Romania, Russian Federation (the), Rwanda, Saudi Arabia, Sudan (the), Senegal, Singapore, Solomon Islands, Sierra Leone, El Salvador, San Marino, Serbia, Sao Tome and Principe, Suriname, Slovakia, Slovenia, Sweden, Swaziland, Seychelles, Syrian Arab Republic (the), Togo, Thailand, Tajikistan, Turkmenistan, Tonga, Trinidad and Tobago, Tunisia, Turkey, Tuvalu, United Republic of Tanzania (the), Uganda, Ukraine, Uruguay, United States of America (the), Uzbekistan, Saint Vincent and the Grenadines, Venezuela (Bolivarian Republic of), Viet Nam, Vanuatu, Samoa, South Africa, Zambia, Zimbabwe Introduction to date (4 countries or 11%) Since January 2013, the following Tier 1 and 2 countries have introduced IPV: The Philippines (October 2014), China (December 2014), Nigeria (February 2015) and DR Congo (April 2015) Formal commitment to introduce in 2015 (31 countries or 89%) Not Applicable or not Tier 1 or 2 countries Tier 1 countries are countries with cVDPV2 transmission or cVDPV2 reported since 2000 & WPV endemic countries Tier 2 countries are countries with cVDPV 1/3 since 2000 or large /Medium size countries with DTP3 coverage <80% in the past 3 years as per WUENIC Data source: WHO/IVB Database, as of 01 May 2015, based on 35 tier 1 & 2 countries Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Date of slide: 1 May 2015

8 World Health Organization
Middle Income Countries using IPV vaccine to date and formal/intent decision to introduce World Health Organization 30 January, 2018 Introduced to date Albania, Belarus, Bosnia and Herzegovina, Brazil, Bulgaria, China, Colombia, Costa Rica, Hungary, Jordan, Kazakhstan, Lebanon, Libya, Malaysia, Maldives, Marshall Islands (the), Mexico, Micronesia (Federated States of), Montenegro, Nigeria, Palau, Panama, Peru, Philippines (the), Romania, Senegal, Serbia, South Africa, Syrian Arab Republic (the), Tunisia, Turkey, Ukraine Formal commitment to introduce in 2015 Algeria, Angola, Argentina, Armenia, Azerbaijan, Belize, Bhutan, Bolivia (Plurinational State of), Botswana, Cabo Verde, Cameroon, Congo (the), Cote d'Ivoire, Cuba, Djibouti, Dominica, Dominican Republic (the), Ecuador, Egypt, El Salvador, Gabon, Georgia, Ghana, Grenada, Guatemala, Guyana, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Kiribati, Lao People's Democratic Republic (the), Lesotho, Mauritania, Mongolia, Morocco, Namibia, Nicaragua, Pakistan, Papua New Guinea, Paraguay, Republic of Moldova (the), Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Seychelles, Solomon Islands, Sri Lanka, Sudan (the), Suriname, Swaziland, The former Yugoslav Republic of Macedonia, Timor-Leste, Tonga, Turkmenistan, Tuvalu, Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia Intend to introduce in 2015 Fiji, Mauritius, Thailand Not Available / Not introduced / No Plans Afghanistan, Algeria, Angola, Antigua and Barbuda, Argentina, Armenia, Azerbaijan, Bahamas (the), Barbados, Belize, Benin, Bhutan, Bolivia (Plurinational State of), Botswana, Burkina Faso, Burundi, Cabo Verde, Cambodia, Cameroon, Central African Republic (the), Chad, Chile, Congo (the), Cote d'Ivoire, Cuba, Djibouti, Dominica, Dominican Republic (the), Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Georgia, Ghana, Grenada, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Honduras, India, Indonesia, Iran (Islamic Republic of), Iraq, Jamaica, Kenya, Kiribati, Kyrgyzstan, Lao People's Democratic Republic (the), Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nicaragua, Niger (the), Pakistan, Papua New Guinea, Paraguay, Republic of Moldova (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Seychelles, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan (the), Suriname, Swaziland, Tajikistan, The former Yugoslav Republic of Macedonia, Timor-Leste, Togo, Tonga, Trinidad and Tobago, Turkmenistan, Tuvalu, Uganda, United Republic of Tanzania (the), Uzbekistan, Vanuatu, Venezuela (Bolivarian Republic of), Viet Nam, Yemen, Zambia, Zimbabwe Since January 2013, the following MIC have introduced IPV: Kazakhstan (July 2013); Peru (July 2013); Libya (March 2014); Albania (May ); Panama (July 2014); Tunisia (September 2014); Philippines (October 2014); China (December 2014); Senegal (January 2015); Serbia (January 2015); Colombia (February 2015) and Maldives (March 2015) Introduced to date (32 countries or 32%) Formal commitment to introduce in 2015 (65 countries or 65%) Intend to introduce in 2015 (Fiji, Mauritius, Thailand) (3 countries or 3%) Data source: WHO/IVB Database, as of 01 May 2015 based on 100 middle income countries (MIC) as per last World Bank classification Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable / Not MIC countries The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Date of slide: 1 May 2015

9 World Health Organization
IPV introduction status and planned introduction by quarter by the end of 2015 World Health Organization 30 January, 2018 Introduced to date Albania, Andorra, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Brunei Darussalam, Bulgaria, Canada, China, Colombia, Comoros (the), Costa Rica, Croatia, Cyprus, Czech Republic (the), Denmark, DPR Korea, DR Congo, Estonia, Finland, France, Gambia (the), Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Latvia, Lebanon, Libya, Lithuania, Luxembourg, Malaysia, Maldives, Malta, Marshall Islands (the), Mexico, Micronesia (Federated States of), Monaco, Montenegro, Nepal, Netherlands (the), New Zealand, Nigeria, Niue, Norway, Oman, Palau, Panama, Peru, Philippines (the), Poland, Portugal, Qatar, Rep of Korea, Romania, Russian Federation (the), San Marino, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Syrian Arab Republic (the), Tunisia, Turkey, Ukraine, United Arab Emirates (the), United Kingdom of Great Britain and Northern Ireland (the), United States of America (the), Uruguay Introduction planned in Q2 2015 Botswana, Cameroon, Chad, Cote d'Ivoire, Grenada, Guyana, Haiti, Kiribati, Lesotho, Madagascar, Mali, Morocco, Nauru, Niger (the), Saint Vincent and the Grenadines, Sudan (the), Tuvalu Introduction planned in Q3 2015 Afghanistan, Argentina, Azerbaijan, Bahamas (the), Benin, Bhutan, Cabo Verde, Central African Republic (the), Chile, Cuba, Djibouti, Dominican Republic (the), Gabon, Ghana, Iran (Islamic Republic of), Iraq, Jamaica, Kenya, Malawi, Mauritania, Mozambique, Myanmar, Namibia, Pakistan, Papua New Guinea, Seychelles, Solomon Islands, South Sudan, Sri Lanka, Swaziland, The former Yugoslav Republic of Macedonia, Timor-Leste, Trinidad and Tobago, Vanuatu Introduction planned in Q4 2015 Algeria, Angola, Antigua and Barbuda, Armenia, Barbados, Belize, Bolivia (Plurinational State of), Burkina Faso, Burundi, Cambodia, Congo (the), Cook Islands, Dominica, Ecuador, Egypt, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Fiji, Georgia, Guatemala, Guinea, Guinea-Bissau, Honduras, India, Indonesia, Kyrgyzstan, Lao People's Democratic Republic (the), Liberia, Mongolia, Nicaragua, Paraguay, Republic of Moldova (the), Rwanda, Saint Kitts and Nevis, Saint Lucia, Samoa, Sao Tome and Principe, Sierra Leone, Somalia, Suriname, Tajikistan, Thailand, Togo, Tonga, Turkmenistan, Uganda, United Republic of Tanzania (the), Uzbekistan, Venezuela (Bolivarian Republic of), Viet Nam, Zambia, Zimbabwe Introduction planned in 2015 but month of introduction not known Mauritius, Yemen Introduced to date (87 countries or 45%) Since January 2013, the following countries have introduced IPV: Kazakhstan & Peru (July 2013); Libya (March 2014); Albania (May 2014); Panama (July 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & ; Nigeria (February 2015); Bangladesh & Maldives (March 2015); DPR Korea, DR Congo and Gambia (April 2015) Introduction planned in Q2 2015 (17 countries or 9%) Introduction planned in Q3 2015 (34 countries or 18%) Introduction planned in Q4 2015 (54 countries or 27%) Introduction planned in 2015 but month of introduction not known (Mauritius, Yemen) (2 countries or 1%) Data source: WHO/IVB Database, as of 01 May 2015 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved. Date of slide: 1 May 2015


Download ppt "World Health Organization"

Similar presentations


Ads by Google